Predictors of radiation pneumonitis and pulmonary function changes after concurrent chemoradiotherapy of non-small cell lung cancer
- PMID: 23620867
- PMCID: PMC3633229
- DOI: 10.3857/roj.2013.31.1.34
Predictors of radiation pneumonitis and pulmonary function changes after concurrent chemoradiotherapy of non-small cell lung cancer
Abstract
Purpose: To evaluate the predictive factors of radiation pneumonitis (RP) and associated changes in pulmonary function after definitive concurrent chemoradiotherapy (CCRT) in patients with non-small cell lung cancer (NSCLC).
Materials and methods: Medical records of 60 patients with NSCLC who received definitive CCRT were retrospectively reviewed. Dose volumetric (DV) parameters, clinical factors, and pulmonary function test (PFT) data were analyzed. RP was graded according to the CTCAE ver. 4.0. Percentage of lung volume that received a dose of threshold (Vdose) and mean lung dose (MLD) were analyzed for potential DV predictors. PFT changes were calculated as the difference between pre-RT and post-RT values at 3, 6, and 12 months after RT.
Results: Twenty-two patients (37%) developed grade ≥2 RP. Among clinical factors, tumor location in lower lobe was associated with RP. Among the DV parameters, only MLD >15 Gy was associated with grade ≥2 RP. There were statistically significant decreases in PFT at all points compared with pre-RT values in grade ≥2 RP group. MLD was associated with forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1) changes at 6 and 12 months. V10 was associated with FVC changes at 12 months. V20 and V30 were associated with FEV1 changes at 6 months and FVC changes at 12 months.
Conclusion: After definitive CCRT in patients with NSCLC, MLD >15 Gy and lower lobe tumor location were predictors of grade ≥2 RP. Pulmonary functions were decreased after CCRT and the magnitude of changes was associated with DV parameters.
Keywords: Dose volumetric parameter; Non-small-cell lung carcinoma; Radiation pneumonitis; Respiratory function test.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures

Similar articles
-
Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis.BMC Cancer. 2019 Nov 26;19(1):1144. doi: 10.1186/s12885-019-6359-9. BMC Cancer. 2019. PMID: 31771538 Free PMC article.
-
Radiation pneumonitis after definitive concurrent chemoradiotherapy with cisplatin/docetaxel for non-small cell lung cancer: Analysis of dose-volume parameters.Cancer Med. 2020 Jul;9(13):4540-4549. doi: 10.1002/cam4.3093. Epub 2020 May 4. Cancer Med. 2020. PMID: 32364685 Free PMC article.
-
Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel.Int J Radiat Oncol Biol Phys. 2010 Dec 1;78(5):1381-6. doi: 10.1016/j.ijrobp.2009.09.030. Epub 2010 Mar 16. Int J Radiat Oncol Biol Phys. 2010. PMID: 20231061 Clinical Trial.
-
Ipsilateral lung dose as a correlative measure for radiation pneumonitis in patients treated with definitive concurrent radiochemotherapy.J Cancer Res Ther. 2023 Jul-Sep;19(5):1153-1159. doi: 10.4103/jcrt.jcrt_618_21. J Cancer Res Ther. 2023. PMID: 37787278
-
Acute severe radiation pneumonitis among non-small cell lung cancer (NSCLC) patients with moderate pulmonary dysfunction receiving definitive concurrent chemoradiotherapy: Impact of pre-treatment pulmonary function parameters.Strahlenther Onkol. 2020 Jun;196(6):505-514. doi: 10.1007/s00066-019-01552-4. Epub 2019 Dec 11. Strahlenther Onkol. 2020. PMID: 31828393
Cited by
-
Preliminary result of definitive radiotherapy in patients with non-small cell lung cancer who have underlying idiopathic pulmonary fibrosis: comparison between X-ray and proton therapy.Radiat Oncol. 2019 Jan 28;14(1):19. doi: 10.1186/s13014-019-1221-4. Radiat Oncol. 2019. PMID: 30691496 Free PMC article.
-
Optimal beam arrangement for pulmonary ventilation image-guided intensity-modulated radiotherapy for lung cancer.Radiat Oncol. 2014 Aug 16;9:184. doi: 10.1186/1748-717X-9-184. Radiat Oncol. 2014. PMID: 25127899 Free PMC article.
-
Radiation-induced lung injury: current evidence.BMC Pulm Med. 2021 Jan 6;21(1):9. doi: 10.1186/s12890-020-01376-4. BMC Pulm Med. 2021. PMID: 33407290 Free PMC article. Review.
-
Pulmonary Function Changes After Radiotherapy for Lung or Esophageal Cancer: A Systematic Review Focusing on Dose-Volume Parameters.Oncologist. 2017 Oct;22(10):1257-1264. doi: 10.1634/theoncologist.2016-0324. Epub 2017 May 26. Oncologist. 2017. PMID: 28550029 Free PMC article.
-
Comparison of post-chemoradiotherapy pneumonitis between Asian and non-Asian patients with locally advanced non-small cell lung cancer: a systematic review and meta-analysis.EClinicalMedicine. 2023 Sep 25;64:102246. doi: 10.1016/j.eclinm.2023.102246. eCollection 2023 Oct. EClinicalMedicine. 2023. PMID: 37781162 Free PMC article.
References
-
- Furuse K, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol. 1999;17:2692–2699. - PubMed
-
- Perez CA, Stanley K, Grundy G, et al. Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung: report by the Radiation Therapy Oncology Group. Cancer. 1982;50:1091–1099. - PubMed
-
- Yorke ED, Jackson A, Rosenzweig KE, et al. Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys. 2002;54:329–339. - PubMed
-
- Kwa SL, Theuws JC, Wagenaar A, et al. Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis. Radiother Oncol. 1998;48:61–69. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources